Knott David M Jr Arcellx, Inc. Transaction History

Knott David M Jr

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$31.51 - $37.4 $630,200 - $748,000	20,000 New	20,000 $718,000
Q2 2023 Aug 11, 2023	BUY	$27.49 - $46.9 $1.1 Million - $1.88 Million	40,000 New	40,000 $1.27 Million
Q1 2023 May 11, 2023	BUY	$26.92 - $33.94 $753,760 - $950,319	28,000 New	28,000 $863,000

210

44.2M

2.23M

907K

Ticker ACLX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,819,200
Market Cap $2.93B
Description
Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It...

Get notified when there are updates to the investment portfolio of Knott David M Jr, based on Form 13F filings with the SEC.

Stay updated on Knott David M Jr with notifications on news.